| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CMG Pharmaceutical Co. Ltd (KQ: 058820)
058820 Technical Analysis
4
| As on 28th Nov 2025 058820 STOCK Price closed @ 2020.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1974.60 & Strong Buy for SHORT-TERM with Stoploss of 1837.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
058820STOCK Price
| Open | 1902.00 | Change | Price | % |
| High | 2050.00 | 1 Day | 124.00 | 6.54 |
| Low | 1882.00 | 1 Week | 275.00 | 15.76 |
| Close | 2020.00 | 1 Month | 161.00 | 8.66 |
| Volume | 3417104 | 1 Year | 49.00 | 2.49 |
| 52 Week High 2975.00 | 52 Week Low 1600.00 | ||||
KQ Korea Most Active Stocks
| 032980 | 302.00 | 16.15% |
| 098460 | 23700.00 | 21.60% |
| 010170 | 2365.00 | 3.73% |
| 043220 | 171.00 | -29.63% |
| 000040 | 670.00 | 12.42% |
| 000040 | 670.00 | 12.42% |
| 092200 | 9090.00 | 24.35% |
| 092200 | 9090.00 | 24.35% |
| 214870 | 1383.00 | -27.44% |
| 054180 | 153.00 | -10.53% |
KQ Korea Top Gainers Stocks
KQ Korea Top Losers Stocks
| 058820 Daily Charts |
058820 Intraday Charts |
Whats New @ Bazaartrend |
058820 Free Analysis |
|
|
058820 Important Levels Intraday
| RESISTANCE | 2343.74 |
| RESISTANCE | 2239.91 |
| RESISTANCE | 2175.74 |
| RESISTANCE | 2111.56 |
| SUPPORT | 1928.44 |
| SUPPORT | 1864.26 |
| SUPPORT | 1800.09 |
| SUPPORT | 1696.26 |
058820 Forecast November 2025
| 4th UP Forecast | 2468.99 |
| 3rd UP Forecast | 2325 |
| 2nd UP Forecast | 2235.99 |
| 1st UP Forecast | 2146.99 |
| 1st DOWN Forecast | 1893.02 |
| 2nd DOWN Forecast | 1804.01 |
| 3rd DOWN Forecast | 1715 |
| 4th DOWN Forecast | 1571.01 |
058820 Weekly Forecast
| 4th UP Forecast | 2617.37 |
| 3rd UP Forecast | 2425.79 |
| 2nd UP Forecast | 2307.37 |
| 1st UP Forecast | 2188.95 |
| 1st DOWN Forecast | 1851.05 |
| 2nd DOWN Forecast | 1732.63 |
| 3rd DOWN Forecast | 1614.21 |
| 4th DOWN Forecast | 1422.63 |
058820 Forecast2025
| 4th UP Forecast | 5401.89 |
| 3rd UP Forecast | 4317.3 |
| 2nd UP Forecast | 3646.89 |
| 1st UP Forecast | 2976.48 |
| 1st DOWN Forecast | 1063.53 |
| 2nd DOWN Forecast | 393.12 |
| 3rd DOWN Forecast | -277.3 |
| 4th DOWN Forecast | -1361.89 |
CMG Pharmaceutical Co. Ltd ( KQ Korea Symbol : 058820 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
058820 Business Profile
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea. Address: Cheongdam-dong 18-20, #B01, Seoul, South Korea, 135-949
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service